Posted inBiotechnology
Jupiter enters psychedelics space with $100M deal for PharmAla’s MDMA drug
Jupiter Neurosciences will pay $3.3 million upfront to Canada's PharmAla Biotech for U.S. rights to an MDMA drug to treat…
Posted inBiotechnology
Agios says adios to sickle cell program over lackluster phase 2 data
A phase 2 study of Agios Pharmaceuticals’ next-generation pyruvate kinase activator has failed to support continued development in sickle cell…
Posted inBiotechnology
Novartis drops phase 2 radioligand therapy, but CEO’s commitment to modality ‘unchanged’
Novartis has dropped a phase 2-stage radioligand therapy after the candidate disappointed in the clinic.
Posted inBiotechnology
Indian generics maker Lupin seeds US spinout Kaveri with cash, clinical-phase cancer assets
Lupin has spun out two clinical-phase cancer drug candidates to create Kaveri Therapeutics, a U.S.-based startup that plans to raise…
Posted inBiotechnology
‘There is always a first’: Why US biotech Axiom will begin its IPO journey in Hong Kong
Axiom Biosciences intends to pursue an IPO on the Hong Kong Stock Exchange (HKEX) followed by a co-listing on the…
Posted inBiotechnology
Kolon’s cell-based gene therapy fails phase 3 osteoarthritis trial
A phase 3 trial of Kolon TissueGene’s cell-based gene therapy has missed its co-primary endpoints. With a second late-stage study…
Posted inBiotechnology
Scribe aims for $96M IPO to fund clinical push for lipid-lowering genetic meds
Scribe Therapeutics has put its IPO plans down on paper, showing the genetic medicine company hopes to raise $96 million…
Posted inBiotechnology
BMS expands AI footprint with Nvidia, aiming for ‘most powerful AI factory in life sciences’
Bristol Myers Squibb has entered into an expanded collaboration with Nvidia to create the biggest supercomputer for drug R&D, according…
Posted inBiotechnology
Latigo preps IPO to fund non-opioid pain drug rival to Vertex’s Journax
Latigo Biotherapeutics is preparing to go public in order to bankroll the development of its clinical-stage pipeline of non-opioid pain…
Posted inBiotechnology
Sleep Quality Links Synergistically with Frailty to Increase Cardiometabolic Multimorbidity in Elderly Chinese
Sleep has long been suspected to influence how aging bodies manage multiple chronic conditions, but the interplay between rest quality…